The Nanopharmaceutics team has a 20+ year track record in development and FDA approval of specialty products.

James D. Talton, Ph.D., is Nanopharmaceutics’ President and the President and CEO of Alchem Laboratories Corporation. Prior to starting Nanopharmaceutics, Dr. Talton served as the President and Chief Executive Officer of Nanotherapeutics, Inc. for seventeen years. He also is President of Discovery Cure Institute, Inc., a Florida non-profit Corporation and serves on the Alumni Advisory Board for the University of Florida Department of Materials Science and Engineering. Dr. Talton has developed multiple clinical-stage products as well as NanoFUSE® DBM, a sterile, FDA-cleared (K062459) easy-to-reconstitute bone graft. Leading multiple successful government programs, Dr. Talton has successfully won over $1 billion in contracts with government partners including NIH, DOD, and BARDA. Dr. Talton is an inventor on thirteen U.S. patents and has authored several peer-reviewed publications and book chapters involved in drug delivery systems with a primary focus in drug analysis and controlled release formulations, pharmacokinetics, and pulmonary drug delivery. Dr. Talton received his B.S. and M.S. in Materials Science and Engineering and his Ph.D. in Pharmaceutical Sciences from the University of Florida.

Jacob has spent the last 25 years working globally in various aspects of corporate finance and consulting, starting in Hong Kong in the late 1990s. To date, he has taken part in bringing at least a dozen companies public in U.S. and foreign markets. His passion has been in building startups, all of which have the commonality of bringing together the brightest minds of a particular industry with pioneering ideas and technological advances. Most recently, he has co-founded two companies on the bleeding edge of digital media production. The first is Monolith Studios, a leading virtual production company that develops, architects, and manages LED-based filming technology for studios such as Marvel, Apple+, Netflix, HBO, and Disney. Recent projects have included: Black Panther 2, Thor: Love and Thunder, and the upcoming Guardians of the Galaxy 3. The second is a "quiet period" company combining artificial intelligence and traditional visual effects to develop the next phase of digital human avatars to be utilized in medicine, enterprise, and entertainment.

Steve Griffith, VFX & VP Executive, DNEG, brings 17 years of industry experience to his role as Executive Producer for DNEG Virtual Production, with recent roles at Rodeo FX as Head Of Production, and at Legend as Vice President of Production. Recent credits include work on Jumanji: The Next Level, Watchmen, The Boys, Stranger Things, and Jungle Cruise. Steve’s career brought him into the field of virtual production just as the broader industry was turning to it for production solutions, and he is focused on hiring, educating, and expanding DNEG’s Virtual Production tool sets and services to evangelise this new technology to the industry.